Software Company w/Patients & Clients

$1.8 MM Offering

Business overview
Company is a Texas‑based remote patient monitoring (RPM) and chronic care management (CCM) platform. Founded in 2015, the company built a HIPAA‑compliant SaaS solution. The system integrates with peripheral devices to collect physiological data, delivers alerts to providers when values exceed thresholds, and includes a dynamic question engine that tailors follow‑up questions by disease state. The platform also features an in‑house help‑desk and programming support. The business has transitioned to a SaaS/licensing model and currently serves roughly 1,500 active patients across 10 provider accounts out of a database of ~20 k patients.

Investment highlights
• Scalable SaaS platform. Built in C++ with AWS hosting and supports RPM and CCM workflows, medication management and a dynamic questionnaire engine. It is HIPAA‑compliant.
• Recurring reimbursement stream. Medicare reimburses remote monitoring and care‑management codes monthly. For example, CPT 99454 (device supply and data transmission) reimburses $43.02 per patient per month. CPT 99457, covering the first 20 minutes of RPM service, pays $47.87 per month, and CPT 99458 (each additional 20 minutes) reimburses $38.49. Non‑complex CCM codes CPT 99490 and 99491 reimburse $60.49 and $82.16 per month respectively. With 1 500 active patients, a buyer could realize >$1.8 million of annual top‑line revenue even before adding new clients.
• Industry tailwinds. Remote patient monitoring adoption is accelerating; industry analysts predict the RPM market will grow 128 % by 2027 and that 71 million Americans will use some type of RPM by 2025. The global RPM market is expected to reach $42 billion by 2028 with a 20 % compound annual growth rate (CAGR).
• Assets included. The balance sheet lists $210 k of inventory, $60 k accounts receivable, $13 k cash, and fixed equipment (monitoring devices, laptops and office equipment) with a net book value of $91 k. There is also $146 k of capitalized software development costs.
• Opportunities. The company currently has minimal marketing and relies on the founder’s relationships. The pipeline can be expanded to additional clinics, hospitals and health‑systems; the dynamic question engine can be licensed as a stand‑alone module; and a medication‑management module in development could create cross‑sell revenue.

Deal summary
• Asking price: $1.8 million (asset sale).
• Structure: All assets of RPM/CCM Company, including proprietary software, inventory and equipment, accounts receivable and customer contracts.